Trial intelligence / Profile preview

Ceftaroline vs Levofloxacin in CABP

NCT01524302Phase 4Completed

Sponsor
Gary E. Stein
Start
Feb 2012
Primary completion
May 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ceftaroline fosamil in community-acquired bacterial pneumonia (CAP), sponsored by Gary E. Stein. Started Feb 2012; status: completed.

02

Drugs

ceftaroline fosamil
03

Conditions

community-acquired bacterial pneumonia (CAP)

Beyond the preview

Go deeper on NCT01524302.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01524302.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call